Abstract
Ergot alkaloids have come to assume a pivotal position in migraine therapy. Not only does this group include the most potent drugs for the relief of the acute attack, but it also provides the most effective prophylactic drugs available.
The paper is being reprinted with the permission of the International Symposium on Headache, October 1969, Chicago, USA.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aellig, W. H. (1967). Periphere Kreislaufwirkungen von Ergotamin, Dihydroergotamin und 1-Methyl-ergotamin an der innervierten, perfundierten Hinterextremität des Hundes. Helv. physiol. pharmacol. Acta, 25, 374.
Aellig, W. H. and Berde, B. (1969). Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed. Brit. J. Pharmacol. 36, 561.
Cerletti, A. and Berde, B. (1969). New approaches in the development of compounds from ergot with potential therapeutic use in migraine. In Background to Migraine. London: William Heinemann Medical Books.
Konzett, H. and Rothlin, E. (1953). Investigations on the hypotensive effect of the hydrogenated ergot alkaloids. Brit. J. Pharmacol. Chemother. 8, 201.
Pacha, W. and Salzmann, R. (1970). Inhibition of the re-uptake of neuronally liberated noradrenaline and α-adrenergic blocking action of some ergot alkaloids. Brit. J. Pharmacol. 38, 439.
Rothlin, E. (1946/47). The pharmacology of the natural and dihydrogenated alkaloids of ergot. Bull. Schweiz. Akad. med. Wiss. 2, 249.
Salzmann, R. and Pacha, W. (1968). Vergleichende Untersuchungen über die Beeinflussung adrenerger Reaktionen durch Ergotamin und Dihydroergotamin an verschiedenen Versuchsmodellen. Helv. physiol. pharmacol. Acta, 26, 246.
Salzmann, R., Pacha, W. and Taeschler, M. et al. (1968). The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the cat. Naunyn-Schmiedebergs Arch. Pharm. exp. Path. 261, 360.
Salzmann, R., Pacha, W. and Weidmann, H. (1967). Der Einfluss von Ergotamin auf humorale und neuronale Wirkungen an der Nickhaut und an der Milz der Katze. Helv. physiol. pharmacol. Acta, 25, 433.
Thoenen, H., Hürlimann, A. and Haefely, W. (1963). The effect of post-ganglionic sympathetic Stimulation on the isolated, perfused spleen of the cat. Helv. physiol. pharmacol. Acta, 21, 17.
Thoenen, H., Hürlimann, A. and Haefely, W. (1964). Dual site of action of phenyoxybenzamine in the cat’s spleen: blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia (Basel), 20, 272.
Udenfriend, S. (1964). Fluorescence Assay in Biology and Medicine, page 158. New York/London, Academic Press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer Science+Business Media New York
About this chapter
Cite this chapter
Berde, B. (1971). New Studies on the Circulatory Effects of Ergot Compounds with Implications to Migraine. In: Cumings, J.N. (eds) Background to Migraine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4577-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4577-1_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4579-5
Online ISBN: 978-1-4757-4577-1
eBook Packages: Springer Book Archive